We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+12.32%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$737M
AUM Growth
+$63.6M
Cap. Flow
+$1.37M
Cap. Flow %
0.19%
Top 10 Hldgs %
57.92%
Holding
79
New
1
Increased
35
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$2.11M
2
CASY icon
Casey's General Stores
CASY
+$1.56M
3
COST icon
Costco
COST
+$1.47M
4
FISV
Fiserv Inc
FISV
+$1.35M
5
LLY icon
Eli Lilly
LLY
+$1.33M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$2.56M
2
NVDA icon
NVIDIA
NVDA
+$2.4M
3
STZ icon
Constellation Brands
STZ
+$2.24M
4
ROK icon
Rockwell Automation
ROK
+$1.26M
5
GNRC icon
Generac Holdings
GNRC
+$454K

Sector Composition

Rank Sector Weight
1 Technology 41.44%
2 Healthcare 17.21%
3 Consumer Discretionary 13.09%
4 Communication Services 7.51%
5 Financials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
76
Comcast
CMCSA
$85B
$206K 0.03%
5,728
-1,722
-23% -$59.6K
IBRX icon
77
ImmunityBio
IBRX
$7.51B
$77K 0.01%
+25,800
New +$69.4K
MRK icon
78
Merck
MRK
$322B
-2,753
Closed -$248K
TGT icon
79
Target
TGT
$65.6B
-2,525
Closed -$263K

Similar funds

Dillon & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Dillon & Associates held 79 positions worth $737M, up 9.4% from $673M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 3.8%. Dillon & Associates opened 1 new position and exited 2, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q2 2025 buy was ImmunityBio: 25,800 shares worth $77K.
  • Dillon & Associates added most to Eaton in Q2 2025, an estimated $2.11M increase.
  • Dillon & Associates's biggest Q2 2025 reduction was PepsiCo, cutting an estimated $2.56M.
  • Dillon & Associates fully exited Target in Q2 2025, selling an estimated $263K.
  • Dillon & Associates's ten largest holdings make up 58% of its $737M portfolio in Q2 2025.
  • Dillon & Associates opened 1 new position and closed 2 in Q2 2025.
  • Dillon & Associates's portfolio value rose 9.4% quarter-over-quarter to $737M.

Based on Dillon & Associates's 13F filing for Q2 2025, filed 5 Aug 2025.